Roxanne Dyas

BPharm 
Murdoch Children’s Research Institute

Roxanne Dyas is a highly experienced paediatric pharmacist with over two decades of specialised expertise in paediatric oncology. She completed her pharmacy training at the Royal Children's Hospital in Melbourne, where she developed a passion for this complex field.

Roxanne is currently an academic pharmacist at the Murdoch Children's Research Institute. Her work is driven by a growing interest in pharmacogenomics, the study of how a person's genes affect their response to drugs. Roxanne is a strong advocate for incorporating pharmacogenomics into clinical practice, believing it has the potential to transform how we treat children.

Her dedication to improving patient outcomes extends to ensuring that consumer voices are at the heart of medical research and practice. She is committed to promoting consumer involvement to ensure that medical advancements truly meet the needs of patients and their families. Through her work, Roxanne strives to raise awareness and drive the integration of these crucial areas, ultimately helping to provide more personalised and effective care for children with cancer.

Projects

Roxanne Dyas

is working on

Articles featuring

Roxanne Dyas

Read our latest news

Meet more people

Dev Note:
This slider will be replaced by the cards above in the published site.
Dev Note:
This slider will be replaced by the cards above in the published site.
Dev Note:
This slider will be replaced by the cards above in the published site.
Dev Note:
This slider will be replaced by the cards above in the published site.
Dev Note:
This slider will be replaced by the cards above in the published site.

Get Involved

CoLaborate with us to accelerate childhood cancer research and innovation

Patient Stories
Collaboration
Innovation Accelerators
Survivorship and Living Well
Future Leaders
Safer Therapies
Next-Generation Therapies
Children’s Cancer CoLab and Maddie Riewoldt’s Vision Clinician-Researcher Fellowship
Future Leaders
Innovation Accelerators
Survivorship and Living Well
Safer Therapies
Next-Generation Therapies